This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Amorepacific Corporation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Kwang-Sik Woe: Innovator in Biochemical Applications
Introduction
Kwang-Sik Woe is a notable inventor based in Chungju, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of agents that influence gene expression and promote the production of beneficial compounds.
Latest Patents
Woe holds 2 patents that showcase his innovative work. His latest patents include an agent for controlling Bcl-2 expression, which comprises ginsenoside F1 as an active component. This invention aims to regulate Bcl-2 expression, which is crucial in various biological processes. Another significant patent is a promoter for the production of hyaluronic acid containing ginsenoside compound K. This invention highlights the efficacy of ginsenoside compound K in increasing the expression of hyaluronic acid synthase gene in human cells, thereby promoting the production of hyaluronic acid and serving as an anti-aging agent.
Career Highlights
Kwang-Sik Woe is associated with Amorepacific Corporation, a leading company in the beauty and cosmetics industry. His work at the company emphasizes the application of his inventions in enhancing skincare products and promoting health benefits through innovative biochemical solutions.
Collaborations
Woe has collaborated with notable colleagues, including Si-Young Cho and Duck-Hee Kim. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Kwang-Sik Woe's contributions to biochemistry through his patents reflect his commitment to innovation and the advancement of health-related applications. His work continues to influence the industry and offers promising solutions for future developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
